At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a longer-lasting form of immunity than an antibody response. BioNTech BNTX, + 3.46% and Pfizer Inc. PFE, + 0.69% It said early Monday morning that an ongoing early-stage clinical trial for …
Read More »Reliance-Google smartphone deal in India threatens Chinese companies
NEW DELHI (Reuters) – A $ 4.5 billion settlement under which Alphabet’s (GOOGL.O) Google will collaborate with Reliance Industries of India (RELI.NS) On a new smartphone it probably heralds a major shake-up for the world’s second-largest mobile market, industry executives and analysts say. FILE PHOTO: The Reliance Industries logo is …
Read More »The Republican senator demands answers after the attack: “Did this attack threaten the security of the President’s own Twitter account?”
“ ‘A successful attack on your system’s servers represents a threat to the privacy and data security of all its users. … Did this attack threaten the security of the President’s own Twitter account? “ – Republican Senator Josh Hawley of Missouri The above lines came Wednesday from Republican Sen. …
Read More »Moderna Shares Increase 17% in News About Coronavirus Vaccine Trials
Posted: Jul 14, 2020 at 6:23 pm ET Moderna headquarters in Cambridge, Massachusetts. fake pictures Moderna Inc.’s shares soared in the extended session Tuesday after the biotech company said its coronavirus vaccine candidate produced a “robust” immune system response in a larger group of people and the study will go …
Read More »Modern Phase 1 results show that the coronavirus vaccine is safe and induces an immune response
CHICAGO (Reuters) – Moderna Inc’s (MRNA.O) The experimental vaccine for COVID-19 was shown to be safe and elicited immune responses in all 45 healthy volunteers in an early-stage study, US researchers reported Tuesday. The volunteers who received two doses of the vaccine had high levels of anti-virus antibodies that exceeded …
Read More »